.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Colorcon
Express Scripts
Mallinckrodt
Cantor Fitzgerald
US Army
Merck
McKinsey
Farmers Insurance
US Department of Justice

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022155

« Back to Dashboard

NDA 022155 describes CHILDREN'S ZYRTEC HIVES RELIEF, which is a drug marketed by J And J Consumer Inc and is included in two NDAs. It is available from two suppliers. There is one patent protecting this drug. Additional details are available on the CHILDREN'S ZYRTEC HIVES RELIEF profile page.

The generic ingredient in CHILDREN'S ZYRTEC HIVES RELIEF is cetirizine hydrochloride. There are thirty-nine drug master file entries for this compound. One hundred and fifty-six suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride profile page.

Summary for 022155

Tradename:2
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details

Medical Subject Heading (MeSH) Categories for 022155

Suppliers and Packaging for NDA: 022155

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CHILDREN'S ZYRTEC ALLERGY cetirizine hydrochloride SYRUP;ORAL 022155 NDA Corporacion Infarmasa 16853-1261 16853-1261-2 2 SYRUP in 1 PACKAGE, COMBINATION (16853-1261-2)
CHILDREN'S ZYRTEC ALLERGY cetirizine hydrochloride SYRUP;ORAL 022155 NDA Corporacion Infarmasa 16853-1261 16853-1261-1 1 SYRUP in 1 CARTON (16853-1261-1)

Summary for product number 001

Active Rx/OTC/Discontinued:OTCDosage:SYRUP;ORALStrength5MG/5ML
Approval Date:Nov 16, 2007TE:RLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:OTCDosage:SYRUP;ORALStrength5MG/5ML
Approval Date:Nov 16, 2007TE:RLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Farmers Insurance
Harvard Business School
AstraZeneca
Julphar
Cipla
Colorcon
US Army
UBS
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot